
CENCORA INC (COR), a large-cap growth stock in the Major Drugs industry, scored 87% on Validea's Multi-Factor Investor model, which applies Pim van Vliet's strategy for identifying low volatility stocks with strong momentum and high net payout yields. This rating signifies "some interest" in COR, aligning with Van Vliet's research advocating for the outperformance potential of low-risk equities, a key consideration for institutional investors seeking conservative yet robust returns.
Cencora Inc. (COR), a large-cap growth stock in the Major Drugs industry, has registered a high score of 87% on Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy of identifying low-volatility stocks with strong momentum and high net payout yields. This score signals notable interest from the quantitative model. The analysis reveals that COR's primary strength lies in its low-risk profile, as it passed the model's criteria for market capitalization and standard deviation. However, its profile is tempered by 'Neutral' ratings for both 'Twelve Minus One Momentum' and 'Net Payout Yield,' indicating it currently lacks the strong performance trends and high capital returns favored by the strategy. Critically, despite the high 87% score, the stock received a 'FAIL' on its 'FINAL RANK', suggesting that the weaknesses in momentum and yield were significant enough to disqualify it from the model's top tier, presenting a mixed quantitative signal for investors.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.05
Ticker Sentiment